Today, Harlem Representative Adriano Espaillat issued the following statement touting successful efforts of the Biden-Harris Administration to lower prescription prices.
This will happen for the first ten drugs that have been negotiated by Medicare.
“Once again, Democrats have delivered because we firmly believe that no one should ever have to choose between putting food on the table and affording the medications they need to survive,” said Rep. Espaillat. “Under the leadership of the Biden-Harris Administration, we took on Big Pharma to lower drug prices – and we won.
“For years, leaders tried to allow Medicare to negotiate directly with drug manufacturers to deliver lower prices for seniors and people with disabilities, but Big Pharma blocked them. President Biden got it done when he signed the Inflation Reduction Act – with Vice President Harris casting the tie-breaking vote. These new, lower prices cut the cost of some of the most expensive and most commonly used drugs by nearly 40 to 80%. These drugs are used to treat everything from blood clots to diabetes, heart disease, cancers, and more.
“The lower prices will go into effect in 2026 and will be felt by the 650,000 Medicare beneficiaries in New York that rely on drugs selected for negotiation. This action builds on the progress the Biden-Harris Administration has already made lowering health care costs, including the Inflation Reduction Act’s $35 insulin cap, which has saved more than 76,000 Medicare enrollees an average of $483 per year, and capping out-of-pocket prescription drug costs at $2,000 for seniors which has saved more than $196 million for enrollees and people with disabilities.”
Click here to read more about the Biden-Harris Administration’s new plan to lower prices for ten drugs selected for Medicare price negotiation to lower costs for millions of Americans.
Representative Espaillat is the first Dominican American to serve in the U.S. House of Representatives and his congressional district includes Harlem, East Harlem, West Harlem, Hamilton Heights, Washington Heights, Inwood, Marble Hill and the north-west Bronx. First elected to Congress in 2016, Representative Espaillat is serving his fourth term in Congress. Representative Espaillat currently serves as a member of the influential U.S. House Committee on Appropriations responsible for funding the federal government’s vital activities and serves as Ranking Member of the Legislative Branch Subcommittee of the committee during the 118th Congress. He is also a member of the House Budget Committee and the Congressional Hispanic Caucus (CHC), where he serves in a leadership role as the Deputy Chair as well as Chair of the Congressional Hispanic Caucus Institute (CHCI). Rep. Espaillat is a member of the Congressional Progressive Caucus (CPC) and serves as a Senior Whip of the Democratic Caucus. To find out more about Rep. Espaillat, visit online at https://espaillat.house.gov/.
- Bronx: NYWF’s 30th Annual Dinner Honors Community Leadership And Purpose
- God’s Love We Deliver Joins Melba Wilson For Special Thanksgiving Turkey Giveaway In Harlem
- Unlocking Business Growth With Strategic SEO Practices
- How To Boost Instagram Story Views Effectively
- The Pros And Cons Of Major Types Of Grills
Spanish
Hoy, el congresista Adriano Espaillat (NY-13) emitió la siguiente declaración para destacar los esfuerzos exitosos de la Administración Biden-Harris para reducir los precios de los medicamentos recetados de los primeros diez que han sido negociados por el Medicare.
“Una vez más, los demócratas hemos obtenido logros porque creemos firmemente que nadie debería tener que elegir entre poner comida en la mesa y pagar los medicamentos que necesita para sobrevivir”, dijo el Rep. Espaillat. “Bajo el liderazgo de la Administración Biden-Harris, nos enfrentamos a las Grandes Farmacéuticas para reducir los precios de los medicamentos –y ganamos.
“Durante años, líderes intentaron permitir que Medicare negociara directamente con los fabricantes de medicamentos para ofrecer precios más bajos para las personas mayores y las personas con discapacidades, pero las Grandes Farmacéuticas lo bloquearon. El presidente Biden lo logró cuando firmó la Ley de Reducción de la Inflación ―con la vicepresidenta Harris emitiendo el voto decisivo. Estos nuevos precios más bajos redujeron el costo de algunos de los medicamentos más caros y de uso más común entre casi un 40% y un 80%. Estos medicamentos se utilizan para tratar todo, desde coágulos de sangre hasta diabetes, enfermedades cardíacas, cánceres y más.
“Los precios más bajos entrarán en vigor en 2026 y los efectos se sentirán en los 650,000 beneficiarios de Medicare en Nueva York que dependen de los medicamentos seleccionados para la negociación. Esta medida se suma al progreso que la Administración Biden-Harris ya ha logrado en la reducción de los costos de la atención médica, incluido el límite del costo de insulina a $35 en la Ley de Reducción de la Inflación, que ha ahorrado a más de 76,000 inscritos en Medicare un promedio de $483 por año, y el límite de los costos de bolsillo de los medicamentos recetados a $2,000 para las personas mayores, lo que ha ahorrado más de $196 millones para los inscritos y las personas con discapacidades”.
Haga clic aquí para leer más sobre el nuevo plan de la Administración Biden-Harris para reducir los precios de diez medicamentos seleccionados por Medicare para negociar los precios a fin de reducir los costos para millones de estadounidenses.
Photo credit: Wiki.
Become a Harlem Insider!
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
